1. Pereira MP, Basta S, Moore J, Ständer S. Prurigo nodularis: aphysician survey to evaluate current perceptions of its classification,clinical experience and unmet need. J Eur Acad Dermatol Venereol.2018;32(12):2224-2229. doi:10.1111/jdv.15107
2. Kwon CD, Khanna R, Williams KA, Kwatra MM, Kwatra SG.Diagnostic Workup and Evaluation of Patients with Prurigo Nodularis.Medicines (Basel). 2019;6(4):97. Published 2019 Sep 26. doi:10.3390/medicines6040097
3. Ständer HF, Elmariah S, Zeidler C, Spellman M, Ständer S. Diagnosticand treatment algorithm for chronic nodular prurigo. J Am AcadDermatol. 2020;82(2):460-468. doi:10.1016/j.jaad.2019.07.022
4. Boozalis E, Tang O, Patel S, et al. Ethnic differences and comorbiditiesof 909 prurigo nodularis patients. J Am Acad Dermatol. 2018;79(4):714-719.e3. doi:10.1016/j.jaad.2018.04.047
5. Cao T, Tey HL, Yosipovitch G. Chronic pruritus in the geriatricpopulation. Dermatol Clin. 2018;36(3):199-211. doi:10.1016/j.det. 2018.02.004
6. Buteau A, Reichenberg J. Psychogenic pruritus and its management.Dermatol Clin. 2018;36(3):309-314. doi:10.1016/j.det.2018.02.015
7. Qureshi AA, Abate LE, Yosipovitch G, Friedman AJ. A systematicreview of evidence-based treatments for prurigo nodularis. J Am AcadDermatol. 2019;80(3):756-764. doi:10.1016/j.jaad.2018.09.020
8. Giura MT, Viola R, Fierro MT, Ribero S, Ortoncelli M. Efficacy ofdupilumab in prurigo nodularis in elderly patient. Dermatol Ther.2020;33(1):e13201. doi:10.1111/dth.13201